Cefixime 400 MG Oral Capsule — RxCUI 409823
RxNorm drug concept · Semantic clinical drug
RxCUI 409823
Semantic clinical drug · SCD
● Current RxNorm concept 8 FDA products
17 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI409823
Official nameCefixime 400 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped8
Package NDCs mapped17
Reported Medicaid activity (SDUD)9,136 prescriptions · 29 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Cefixime: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It is an antibiotic for certain bacterial infections: urinary tract infections, throat and tonsil infections, flare-ups of chronic bronchitis, and uncomplicated gonorrhea. Capsules...
- Take it by mouth, usually once a day or split into two doses, exactly as prescribed. Tablets and capsules can be taken with or without food. Finish the full course, which is at lea...
- Stomach upset is the most common: diarrhea, nausea, loose stools, belly pain, and gas. Call your doctor if diarrhea is severe or lasts, since it can sometimes signal a C. difficile...
- Tell me and your prescriber before starting. Cross-allergy between penicillins and cephalosporins can happen in up to 10% of people with a penicillin allergy. Don't take cefixime i...
🕸️ Concept Web — How Cefixime 400 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Cefixime 400 MG Oral Capsule
RxCUI 409823 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Cefixime
25033IN
-
Cefixime
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Suprax
196499BN
-
Suprax
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Cefixime Oral Capsule
438392SCDF -
Cefixime Oral Product
1152096SCDG -
Cefixime Pill
1152097SCDG -
Cefixime Oral Capsule [Suprax]
1372998SBDF -
Suprax Oral Product
1184868SBDG -
Suprax Pill
1184869SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Cefixime Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Cefixime 400 MG
317623SCDC -
Cefixime 400 MG Oral Capsule [Suprax]
1372999SBD -
Cefixime 400 MG [Suprax]
573772SBDC
-
Cefixime 400 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Cefixime 400 MG
SCDC · 317623 -
Cefixime Oral Capsule
SCDF · 438392 -
Cefixime Oral Product
SCDG · 1152096 -
Cefixime Pill
SCDG · 1152097
Brand-Name Concepts
-
Cefixime 400 MG Oral Capsule [Suprax]
SBD · 1372999 -
Cefixime 400 MG [Suprax]
SBDC · 573772 -
Cefixime Oral Capsule [Suprax]
SBDF · 1372998 -
Suprax Oral Product
SBDG · 1184868 -
Suprax Pill
SBDG · 1184869 -
Suprax
BN · 196499
📦 FDA Products & Package NDCs
8 products · 17 package NDCs
17 package NDCs map to RxCUI 409823 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 59651-0647-10 | 1 BLISTER PACK in 1 CARTON (59651-647-10) / 10 CAPSULE in 1... | Cefixime | Aurobindo Pharma Limited | 2026-03-23 |
| 59651-0647-50 | 50 CAPSULE in 1 BOTTLE (59651-647-50) | Cefixime | Aurobindo Pharma Limited | 2026-03-23 |
| 67877-0584-01 | 100 CAPSULE in 1 BOTTLE (67877-584-01) | CEFIXIME | Ascend Laboratories, LLC | 2018-10-12 |
| 67877-0584-05 | 500 CAPSULE in 1 BOTTLE (67877-584-05) | CEFIXIME | Ascend Laboratories, LLC | 2018-10-12 |
| 67877-0584-33 | 10 BLISTER PACK in 1 CARTON (67877-584-33) / 10 CAPSULE in... | CEFIXIME | Ascend Laboratories, LLC | 2020-11-26 |
| 67877-0584-50 | 50 CAPSULE in 1 BOTTLE (67877-584-50) | CEFIXIME | Ascend Laboratories, LLC | 2018-10-12 |
| 68180-0405-01 | 50 mL in 1 BOTTLE (68180-405-01) | CEFIXIME | Lupin Pharmaceuticals, Inc. | 2015-04-24 |
| 68180-0407-03 | 50 mL in 1 BOTTLE (68180-407-03) | CEFIXIME | Lupin Pharmaceuticals, Inc. | 2015-04-24 |
| 68180-0407-04 | 75 mL in 1 BOTTLE (68180-407-04) | CEFIXIME | Lupin Pharmaceuticals, Inc. | 2015-04-24 |
| 68180-0423-08 | 50 CAPSULE in 1 BOTTLE (68180-423-08) | CEFIXIME | Lupin Pharmaceuticals, Inc. | 2020-10-14 |
| 68180-0423-11 | 1 BLISTER PACK in 1 CARTON (68180-423-11) / 10 CAPSULE in 1... | CEFIXIME | Lupin Pharmaceuticals, Inc. | 2020-10-14 |
| 70518-2749-02 | 2 CAPSULE in 1 BOTTLE, PLASTIC (70518-2749-2) | CEFIXIME | REMEDYREPACK INC. | 2021-01-26 |
| 70518-2749-05 | 2 POUCH in 1 BOX (70518-2749-5) / 1 CAPSULE in 1 POUCH (705... | CEFIXIME | REMEDYREPACK INC. | 2023-07-07 |
| 70518-3221-02 | 2 POUCH in 1 BOX (70518-3221-2) / 1 CAPSULE in 1 POUCH (705... | CEFIXIME | REMEDYREPACK INC. | 2021-11-04 |
| 70518-3221-04 | 2 CAPSULE in 1 BOTTLE, PLASTIC (70518-3221-4) | CEFIXIME | REMEDYREPACK INC. | 2022-03-02 |
| 83112-0400-00 | 2 CAPSULE in 1 PACKET (83112-400-00) | Cefixime 400 mg | Health Department, Oklahoma State | 2018-10-12 |
| 83112-0400-02 | 2 CAPSULE in 1 PACKET (83112-400-02) | Cefixime 400 mg | Health Department, Oklahoma State | 2018-10-12 |
Observed labelers:
Lupin Pharmaceuticals, Inc. (5) ·
Ascend Laboratories, LLC (4) ·
REMEDYREPACK INC. (4) ·
Aurobindo Pharma Limited (2) ·
Health Department, Oklahoma State (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.